Literature DB >> 6582782

Segregation and linkage analyses of von Hippel Lindau disease among 220 descendants from one kindred.

R C Go, J M Lamiell, Y E Hsia, J W Yuen, Y Paik.   

Abstract

Von Hippel Lindau disease (vHL), an autosomal dominant precancerous condition, had segregated in a large kindred. Fourteen relatives were known to have been affected; record reviews disclosed features of vHL in 15 previously undiagnosed relatives; presymptomatic evaluations detected vHL in 13 additional members of this kindred. Altogether, among 220 descendants of an ancestral couple, 41 had vHL. We screened for HLA haplotypes and for polymorphic gene markers at 31 loci in 102 direct descendants and 16 spouses from this kindred, including 23 with vHL. Linkage analyses failed to reveal a significant lod score with any locus tested, or any HLA linkage disequilibrium. Expression of vHL among the affected relatives was compared with 384 other reported cases of vHL. The age of onset, tissue involvement, and life expectancy in this family were similar to the other reported cases. The sigmoid age-of-onset distribution for vHL most closely matched a square-foot transformation (mean = 26.2(-2) years; variance = 1.224).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6582782      PMCID: PMC1684404     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Sequential tests for the detection of linkage.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1955-09       Impact factor: 11.025

2.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1--1978.

Authors: 
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

3.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

4.  How many polymorphic genes will it take to span the human genome?

Authors:  K Lange; M Boehnke
Journal:  Am J Hum Genet       Date:  1982-11       Impact factor: 11.025

5.  Bilateral renal masses.

Authors:  E M Blight; R D Biggers; D W Soderdahl; S A Brosman; J M Lamiell; E N Raleigh
Journal:  J Urol       Date:  1980-11       Impact factor: 7.450

6.  A plea for conservation of kidney in renal adenocarcinoma associated with von Hippel-Lindau disease.

Authors:  J C Pearson; J Weiss; E A Tanagho
Journal:  J Urol       Date:  1980-12       Impact factor: 7.450

7.  Early identification of retinal angiomas in a large kindred von Hippel-Lindau disease.

Authors:  F G Salazar; J M Lamiell
Journal:  Am J Ophthalmol       Date:  1980-04       Impact factor: 5.258

8.  Von Hippel-Lindau disease simulating polycystic kidney disease.

Authors:  J M Lamiell; R A Stor; Y E Hsia
Journal:  Urology       Date:  1980-03       Impact factor: 2.649

Review 9.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

10.  Study of the genetic transmission of hypercholesterolemia and hypertriglyceridemia in a 195 member kindred.

Authors:  R C Elston; K K Namboodiri; C J Glueck; R Fallat; R Tsang; V Leuba
Journal:  Ann Hum Genet       Date:  1975-07       Impact factor: 1.670

View more
  10 in total

1.  Von Hippel-Lindau disease in a Newfoundland kindred.

Authors:  J S Green; M I Bowmer; G J Johnson
Journal:  CMAJ       Date:  1986-01-15       Impact factor: 8.262

2.  Central nervous system haemangioblastoma: a clinical and genetic study of 52 cases.

Authors:  A M Boughey; N A Fletcher; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

3.  Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

Authors:  B R Seizinger; D I Smith; M R Filling-Katz; H Neumann; J S Green; P L Choyke; K M Anderson; R N Freiman; S M Klauck; J Whaley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

4.  Genetic mapping of dinucleotide repeat polymorphisms and von Hippel-Lindau disease on chromosome 3p25-26.

Authors:  M A Pericak-Vance; K J Nunes; E Whisenant; D B Loeb; K W Small; J M Stajich; J B Rimmler; L H Yamaoka; D I Smith; H A Drabkin
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

5.  Cytogenetic studies on three pheochromocytomas derived from patients with von Hippel-Lindau syndrome.

Authors:  M Kiechle-Schwarz; H P Neumann; H J Decker; C Dietrich; B Wullich; W Schempp
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

6.  Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Authors:  J M Whaley; J Naglich; L Gelbert; Y E Hsia; J M Lamiell; J S Green; D Collins; H P Neumann; J Laidlaw; F P Li
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

7.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

8.  von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis.

Authors:  M Yao; F Latif; M L Orcutt; I Kuzmin; T Stackhouse; F W Zhou; K Tory; F M Duh; F Richards; E Maher
Journal:  Hum Genet       Date:  1993-12       Impact factor: 4.132

Review 9.  Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma.

Authors:  Zofia Felicja Bielecka; Anna Małgorzata Czarnecka; Cezary Szczylik
Journal:  Front Oncol       Date:  2014-07-25       Impact factor: 6.244

10.  Molecular genetic diagnosis of von Hippel-Lindau disease: analysis of five Japanese families.

Authors:  H Kanno; T Shuin; K Kondo; S Ito; M Hosaka; S Torigoe; S Fujii; Y Tanaka; I Yamamoto; I Kim; M Yao
Journal:  Jpn J Cancer Res       Date:  1996-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.